Conversely, compounds effectively treated allergic rhinitis (Zhou et al., 2021) and influenza (Ti et al., 2021) through inhibiting STAT1 signaling, reducing the expression of inflammatory mediators, and regulating cell differentiation. Here, STAT1 is linked to influenza.